Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial And Strategic Analysis Review
Jiangsu Hengrui Medicine Co., Ltd
Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic Analysis Review
Jiangsu Hengrui Medicine Co., Ltd. (Jiangsu Hengrui) is a biopharmaceutical company engaged in the manufacturing and distribution of pharmaceutical tablets, injections and raw materials. The product portfolio of Jiangsu Hengrui include active pharmaceutical ingredients (APIs), antineoplastics drugs, anesthetics, angiomyocardiac drugs, antibiotic, raw materials and other drugs. The company distributes its products in the domestic markets as well as internationally. It has five subsidiaries which are engaged in the development and sale of medical products. Jiangsu Hengrui is headquartered at Lianyungang in Jiangsu Province, China
This comprehensive SWOT profile of Jiangsu Hengrui Medicine Co., Ltd. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Jiangsu Hengrui Medicine Co., Ltd., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
For more information, please visit:
http://www.aarkstore.com/reports/Jiangsu-Hengrui-Medicine-Co-Ltd-600276-Financial-and-Strategic-Analysis-Review-47554.html
Aarkstore Enterprise
Name: Jessica
Email: Jessica@aarkstore.com
Url: http://www.aarkstore.com/
Contact: 08149852585
by: Aarkstore Enterprise
Dental Medicine And Its Major Changes Can You Beat A Drug Test? MyBestPicksEver Alert: (OTC:HEME) Seems Ready to revolutionize the medical system Medical Coding Transcription - Outsource Is A Better Option Jilin Aodong Medicine Industry Group Co., Ltd. (623) - Financial And Strategic Analysis Review Medical Malpractice: What to Do? Top 10 E-prescription and medical Practice softwares and EMR solution The Main Benefits Of Getting A Medical Coding Certificate Know how to take your medicine right Choosing The Right Medical Transcription Company When Outsourcing Drug Rehab Center: How To Choose The Best Learn The Secrets Depression Drugs - Is More Than One Really Necessary? 15 States of Medical Marijuana
Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial And Strategic Analysis Review Anaheim